Loading...

A PHASE I STUDY OF INTRAVENOUS OR INTRAPERITONEAL PLATINUM BASED CHEMOTHERAPY IN COMBINATION WITH VELIPARIB AND BEVACIZUMAB IN NEWLY DIAGNOSED OVARIAN, PRIMARY PERITONEAL AND FALLOPIAN TUBE CANCER

BACKGROUND: Improvements in disease free survival for epithelial ovarian, peritoneal or fallopian tube cancer (EOC) will only come with improved primary therapy. Incorporation of poly-ADP-ribose inhibitors (PARPi) in the frontline setting may represent one strategy. This study sought to determine th...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Gynecol Oncol
Main Authors: Moore, Kathleen N., Miller, Austin, Bell-McGuinn, Katherine M, Schilder, Russell J, Walker, Joan L, O’Cearbhaill, Roisin E, Guntupalli, Saketh R, Armstrong, Deborah K., Hagemann, Andrea R., Gray, Heidi J., Duska, Linda R., Mathews, Cara A, Chen, Alice, O’Malley, David, Gordon, Sarah, Fracasso, Paula M, Aghajanian, Carol
Format: Artigo
Sprog:Inglês
Udgivet: 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7048389/
https://ncbi.nlm.nih.gov/pubmed/31708167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2019.10.012
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!